Menu

Jade Biosciences, Inc. (JBIO) Presents at UBS Global Biopharma Conference 2026 Transcript
📰

Jade Biosciences, Inc. (JBIO) Presents at UBS Global Biopharma Conference 2026 Transcript

All Articles on Seeking Alpha·about 22 hours ago
#H5aoOgSY
#seekingalpha#research#jade#michael#igan
Reading 0:00
15s threshold

Jade Biosciences, Inc. ( JBIO ) UBS Global Biopharma Conference 2026 November 16, 2026 7:00 AM EST

Company Participants

Tom Frohlich - President, CEO & Director

Andrew King - President of Research & Development

Conference Call Participants

Michael Yee - UBS Investment Bank, Research Division

Presentation

Michael Yee

UBS Investment Bank, Research Division

All right. I get to say good afternoon. It's 12:00. Thank you very much for being with us here at the UBS Biopharma Conference. I'm Michael Yee, Senior Biotechnology and Pharma analyst here at UBS. And very excited to have Jade Biosciences up here with us. That includes the CEO, Tom Frohlich; and President of Research and Development, Dr. Andrew King. Thank you, guys, for being here.

A lot going on in IgAN. And so I would love to turn it over to Tom, just briefly, you could give us an introduction to Jade Biosciences. You have a potential best-in-class APRIL inhibitor for the treatment of IgAN. There's a lot of competitors in this space.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.